0001477932-15-007524.txt : 20151208 0001477932-15-007524.hdr.sgml : 20151208 20151207192320 ACCESSION NUMBER: 0001477932-15-007524 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 505 ITEM INFORMATION: 06b ITEM INFORMATION: 4a5 FILED AS OF DATE: 20151208 DATE AS OF CHANGE: 20151207 EFFECTIVENESS DATE: 20151208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pivot Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001464165 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-252581 FILM NUMBER: 151273851 BUSINESS ADDRESS: STREET 1: 1275 WEST 6TH AVENUE CITY: VANCOUVER STATE: A1 ZIP: V6H 1A6 BUSINESS PHONE: 604 805 7783 MAIL ADDRESS: STREET 1: 1275 WEST 6TH AVENUE CITY: VANCOUVER STATE: A1 ZIP: V6H 1A6 FORMER COMPANY: FORMER CONFORMED NAME: Neurokine Pharmaceuticals Inc. DATE OF NAME CHANGE: 20090514 D 1 primary_doc.xml X0707 D LIVE 0001464165 Pivot Pharmaceuticals Inc. 1275 WEST 6TH AVENUE SUITE 300 VANCOUVER A1 BRITISH COLUMBIA, CANADA V6H 1A6 604 805 7783 BRITISH COLUMBIA, CANADA Neurokine Pharmaceuticals Inc. Corporation true Pravin Chaturvedi 25-K Olympia Avenue Suite 300 Woburn MA MASSACHUSETTS 01801 Executive Officer Director Ahmad Doroudian 1275 West 6th Avenue Suite 300 Vancouver A1 BRITISH COLUMBIA, CANADA V6H 1A6 Director Patrick Frankham 1275 West 6th Avenue Suite 300 Vancouver A1 BRITISH COLUMBIA, CANADA V6H 1A6 Director Wolfgang Renz 1275 West 6th Avenue Suite 300 Vancouver A1 BRITISH COLUMBIA, CANADA V6H 1A6 Director Moira Ong 1275 West 6th Avenue Suite 300 Vancouver A1 BRITISH COLUMBIA, CANADA V6H 1A6 Executive Officer Chief Financial Officer Pharmaceuticals No Revenues 05 06b 4a5 false 2015-11-20 false true true Merger pursuant to which Pivot Pharmaceuticals, Inc. acquired IndUS Pharmaceuticals, Inc. 0 None None None None 1275 West 6th Avenue Suite 300 Vancouver A1 BRITISH COLUMBIA, CANADA V6H 1A6 CA CALIFORNIA MA MASSACHUSETTS VA VIRGINIA false 4227500 4227500 0 The securities were issued pursuant to a merger of Pivot Pharmaceuticals, Inc. and IndUS Pharmaceuticals, Inc. in which 4,750,000 shares of Pivot were issued at a price of $0.89 per share. false 9 0 0 0 The securities are issued pursuant to a merger. false Pivot Pharmaceuticals Inc. /s/ Pravin Chaturvedi Pravin Chaturvedi Chief Executive Officer 2015-12-07